Basics ADiTx Therapeutics, Inc. IPO Date: June 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.72M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 6.00% Avg Daily Range (30 D): $0.31 | 10.12% Avg Daily Range (90 D): $0.14 | 6.72% Institutional Daily Volume Avg Daily Volume: 5.76M Avg Daily Volume (30 D): 13.17M Avg Daily Volume (90 D): 5.01M Trade Size Avg Trade Size (Sh.): 637 Avg Trade Size (Sh.) (30 D): 509 Avg Trade Size (Sh.) (90 D): 462 Institutional Trades Total Inst.Trades: 23 Avg Inst. Trade: $.7M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.51M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.99M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Nov 13, 2025 @ 9:05 PM Evofem Reports Financial Results for Third Quarter... Source: Prnewswire Oct 20, 2025 @ 8:19 PM Evofem Announces Voting Results from Special Meeti... Source: Prnewswire Sep 11, 2025 @ 1:18 PM Evofem's "Say Vagina" Campaign Generates More than... Source: Prnewswire Sep 9, 2025 @ 1:28 PM Evofem Anticipates Approval of Merger with Aditxt ... Source: Prnewswire Aug 19, 2025 @ 1:39 PM FDA Orange Book Lists New U.S. Patent for SOLOSEC,... Source: Prnewswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $14766198.23 $-548.78 $-3.45 Diluted EPS $14766198.23 $-548.78 $-3.45 Revenue $ .01M $ M $ M Gross Profit $ -.07M $ M $ M Net Income / Loss $ -43.1M $ -24.21M $ -7.4M Operating Income / Loss $ -20.55M $ -3.14M $ -6.15M Cost of Revenue $ .07M $ M $ M Net Cash Flow $ -.17M $ -.16M $ -.51M PE Ratio 0.00     Splits Nov 03, 2025:   1:113 Mar 17, 2025:   1:250 Oct 02, 2024:   1:40 Aug 18, 2023:   1:40 Sep 14, 2022:   1:50